Possible Use of Blood Tryptophan Metabolites as Biomarkers for Coronary Heart Disease in Sudden Unexpected Death

MLA

Yutti Amornlertwatana, et al. “Possible Use of Blood Tryptophan Metabolites as Biomarkers for Coronary Heart Disease in Sudden Unexpected Death.” Metabolites, vol. 10, Dec. 2019, p. 6. EBSCOhost, https://doi.org/10.3390/metabo10010006.

APA

Yutti Amornlertwatana, Churdsak Jaikang, Thanapat Sastraruji, & Kobchai Santisukwongchote. (2019). Possible Use of Blood Tryptophan Metabolites as Biomarkers for Coronary Heart Disease in Sudden Unexpected Death. Metabolites, 10, 6. https://doi.org/10.3390/metabo10010006

Chicago

Yutti Amornlertwatana, Churdsak Jaikang, Thanapat Sastraruji, and Kobchai Santisukwongchote. 2019. “Possible Use of Blood Tryptophan Metabolites as Biomarkers for Coronary Heart Disease in Sudden Unexpected Death.” Metabolites 10 (December): 6. doi:10.3390/metabo10010006.